These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25263004)

  • 41. Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection.
    Yang YH; Chen WC; Tsan YT; Chen MJ; Shih WT; Tsai YH; Chen PC
    J Hepatol; 2015 Nov; 63(5):1111-7. PubMed ID: 26196278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Tsan YT; Lee CH; Ho WC; Lin MH; Wang JD; Chen PC
    J Clin Oncol; 2013 Apr; 31(12):1514-21. PubMed ID: 23509319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan.
    Lai SW; Muo CH; Liao KF; Sung FC; Chen PC
    Am J Gastroenterol; 2011 Sep; 106(9):1697-704. PubMed ID: 21577242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonapnea sleep disorders are associated with subsequent ischemic stroke risk: a nationwide, population-based, retrospective cohort study.
    Huang WS; Tsai CH; Lin CL; Sung FC; Chang YJ; Kao CH
    Sleep Med; 2013 Dec; 14(12):1341-7. PubMed ID: 24211072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study.
    Wang CS; Wang ST; Yao WJ; Chang TT; Chou P
    Am J Epidemiol; 2007 Jul; 166(2):196-203. PubMed ID: 17496314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women.
    Cedarbaum E; Ma Y; Scherzer R; Price JC; Adimora AA; Bamman M; Cohen M; Fischl MA; Matsushita K; Ofotokun I; Plankey M; Seaberg EC; Yin MT; Grunfeld C; Vartanian S; Sharma A; Tien PC
    AIDS; 2019 Nov; 33(13):2025-2033. PubMed ID: 31335806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection.
    Park H; Adeyemi A; Henry L; Stepanova M; Younossi Z
    J Viral Hepat; 2015 Nov; 22(11):897-905. PubMed ID: 25904153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
    Peters L; Grint D; Lundgren JD; Rockstroh JK; Soriano V; Reiss P; Grzeszczuk A; Sambatakou H; Mocroft A; Kirk O;
    AIDS; 2012 Sep; 26(15):1917-26. PubMed ID: 22781222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.
    Lee JJ; Lin MY; Yang YH; Lu SN; Chen HC; Hwang SJ
    Am J Kidney Dis; 2010 Jul; 56(1):23-31. PubMed ID: 20400217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes.
    Mueller T; Hinterreiter F; Luft C; Poelz W; Haltmayer M; Dieplinger B
    J Vasc Surg; 2014 May; 59(5):1291-9. PubMed ID: 24393280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan.
    Hsu YH; Hung PH; Muo CH; Tsai WC; Hsu CC; Kao CH
    Medicine (Baltimore); 2015 Nov; 94(47):e2113. PubMed ID: 26632730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection.
    Chen HC; Chung CH; Wang CH; Lin JC; Chang WK; Lin FH; Tsao CH; Wu YF; Chien WC
    PLoS One; 2017; 12(4):e0175266. PubMed ID: 28384326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of developing sudden sensorineural hearing loss in diabetic patients: a population-based cohort study.
    Lin SW; Lin YS; Weng SF; Chou CW
    Otol Neurotol; 2012 Dec; 33(9):1482-8. PubMed ID: 23064384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease - a nationwide cohort study.
    Lin MS; Chen TH; Lin WY; Liu CH; Hsieh YY; Chiu WN; Chang CH; Chen MY; Chung CM; Lin YS
    BMC Gastroenterol; 2017 Aug; 17(1):99. PubMed ID: 28814273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Herpes zoster infection increases the risk of peripheral arterial disease: A nationwide cohort study.
    Lin TY; Yang FC; Lin CL; Kao CH; Lo HY; Yang TY
    Medicine (Baltimore); 2016 Aug; 95(35):e4480. PubMed ID: 27583856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C Virus Infection Is Associated With an Increased Risk of Active Tuberculosis Disease: A Nationwide Population-Based Study.
    Wu PH; Lin YT; Hsieh KP; Chuang HY; Sheu CC
    Medicine (Baltimore); 2015 Aug; 94(33):e1328. PubMed ID: 26287416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a population-based cohort study.
    Shen TC; Lin CL; Chen CH; Tu CY; Hsia TC; Shih CM; Hsu WH; Sung FC
    QJM; 2014 Jul; 107(7):537-43. PubMed ID: 24497528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Risk of Peripheral Arterial Disease after Parathyroidectomy in Patients with End-Stage Renal Disease.
    Hsu YH; Yu HY; Chen HJ; Li TC; Hsu CC; Kao CH
    PLoS One; 2016; 11(6):e0156863. PubMed ID: 27284924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
    Chen CL; Yang HI; Yang WS; Liu CJ; Chen PJ; You SL; Wang LY; Sun CA; Lu SN; Chen DS; Chen CJ
    Gastroenterology; 2008 Jul; 135(1):111-21. PubMed ID: 18505690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.